Rank #1759XERS

Xeris Biopharma Holdings, Inc.

$6.73

-4.27% (Daily)

Market Cap

$1.12B

Revenue

$266.14M

Rank by MCap

#1759

Sector

Healthcare

Industry

Biotechnology

CEO

Mr. John P. Shannon

Headquarters

Chicago, IL

Employees

394

About Xeris Biopharma Holdings, Inc.

Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for ...